Ovarian cancer begins in the ovaries but typically goes undetected until it is found in the pelvis and abdomen, making it difficult to treat and commonly fatal. There are three types of ovarian cancer that differentiate depending on location of where it began: cancer than begins in the cells on the outside of the ovaries, cancer that begins in the egg-producing cells, and cancer that begins in the hormone-producing cells. Risk factors for ovarian cancer include inherited gene mutations, a family history of ovarian cancer, increasing age, and never being pregnant. Treatments for ovarian cancer most frequently include surgery and chemotherapy. Stage III ovarian cancer occurs when the cancer is in one or both of the ovaries and either one or both are present: 1) the cancer has spread to the lining of the abdomen, 2) the cancer has spread to the lymph nodes. The third stage of cancer can be divided into subgroups IIA, IIB, and IIC. Stage IIIC is when cancer is present in both ovaries and/or cancer has spread to the lymph nodes and deposits of cancer (larger than 2 cm) can be seen on the abdomen.
Stage Iiic Ovarian Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iiic Ovarian Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 364 products for the study of Stage Iiic Ovarian Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.